RMD · ResMed Inc.
Healthcare NYQ United States resmed.com ↗
BULLISH BUY
Val Gro Qua Mom Sta Cap P/S5.61 P/E Fwd P/E17.74 PEG1.21 52W –  RSI Target$248.6 (+16.0%) Beta0.78 Div1.12%
Loading chart…
RSI (14)
Pattern Overlays
Loading patterns…
Medical Instruments & Supplies San Diego, United States 10,600 employees
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
52-Week Range
52W Low 52W High
Position in Range
RSI (14)
0 · Oversold RSI 61 Overbought · 100
Signal Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
3Bullish
3Bearish
0Neutral
▲ Double Bottom — Two lows ~$182.46 — bullish reversal confirmed
▲ Inv. Head & Shoulders — Inv. H&S neckline ~$205.87 broken — major bullish reversal
▲ Bull Flag — Breakout after +9% pole — bullish continuation
▼ Bear Flag — Breakdown after -9% pole — bearish continuation
▼ Bear Flag — Breakdown after -10% pole — bearish continuation
▼ Bear Flag — Breakdown after -10% pole — bearish continuation

View overlays on the price chart via Chart tab → Pattern Overlays.

Next Earnings Aug 06, 2026
Beat Rate 100%
Consensus BUY
Analyst Upside +16.0%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
100% 8/8 quarters
Wall Street Consensus
BUY
7
10
1
BuyHoldSell
Price Target Range
$248.6 +16.0% upside
Low $180 High $325
Consensus Current price
Wall Street Analyst Ratings
FirmRatingChangeActionDate
Mizuho Outperform ↔ Maintain 2026-07-15
Citigroup Neutral Buy Neutral ▼ Downgrade 2026-07-13
Jefferies Hold ↔ Maintain 2026-07-10
RBC Capital Outperform ↔ Maintain 2026-07-08
Wells Fargo Equal-Weight ↔ Maintain 2026-07-08
Keybanc Overweight ↔ Maintain 2026-06-22
Morgan Stanley Equal-Weight Overweight Equal-Weight ▼ Downgrade 2026-06-17
Piper Sandler Neutral ↔ Maintain 2026-01-30
Stifel Hold ↔ Maintain 2026-01-30
Baird Neutral Outperform Neutral ▼ Downgrade 2025-12-16
Mizuho 2026-07-15
Outperform ↔ Maintain
Citigroup 2026-07-13
Neutral (from Buy) ▼ Downgrade
Jefferies 2026-07-10
Hold ↔ Maintain
RBC Capital 2026-07-08
Outperform ↔ Maintain
Wells Fargo 2026-07-08
Equal-Weight ↔ Maintain
Keybanc 2026-06-22
Overweight ↔ Maintain
Morgan Stanley 2026-06-17
Equal-Weight (from Overweight) ▼ Downgrade
Piper Sandler 2026-01-30
Neutral ↔ Maintain
Stifel 2026-01-30
Hold ↔ Maintain
Baird 2025-12-16
Neutral (from Outperform) ▼ Downgrade
Profitability
Gross Margin 62.18%TTM
Op. Margin 35.33%TTM
ROE 25.25%TTM
Rev. Growth 10.80%YoY
Free Cash Flow 1.45BTTM
FCF Yield TTM
Balance Sheet
Debt / Equity 12.99MRQ
Current Ratio 3.01MRQ
Cash 1.66BMRQ
Total Debt 843.17MMRQ
Net Debt MRQ
Income
Div. Yield 1.12%TTM
Annual Rate 2.40Fwd
Payout Ratio 22.47%TTM
Dividend History
Payout Ratio (TTM): 22.47%
DateAmount / ShareYield at Payment
2026-05-14 $0.6000 0.30%
2026-02-12 $0.6000 0.24%
2025-11-13 $0.6000 0.24%
2025-08-14 $0.6000 0.21%
2025-05-08 $0.5300 0.22%
2025-02-13 $0.5300 0.22%
2024-11-07 $0.5300 0.22%
2024-08-15 $0.5300 0.24%
2024-05-08 $0.4800 0.23%
2024-02-07 $0.4800 0.26%
2023-11-08 $0.4800 0.33%
2023-08-16 $0.4800 0.28%
2023-05-10 $0.4400 0.19%
2023-02-08 $0.4400 0.20%
2022-11-09 $0.4400 0.21%
2022-08-17 $0.4400 0.19%
2022-05-11 $0.4200 0.23%
2022-02-09 $0.4200 0.18%
2021-11-09 $0.4200 0.17%
2021-08-18 $0.4200 0.16%
2021-05-12 $0.3900 0.21%
2021-02-10 $0.3900 0.20%
2020-11-10 $0.3900 0.19%
2020-08-19 $0.3900 0.22%
2020-05-13 $0.3900 0.25%
2020-02-12 $0.3900 0.24%
2019-11-06 $0.3900 0.29%
2019-08-14 $0.3900 0.32%
2019-05-08 $0.3700 0.35%
2019-02-06 $0.3700 0.41%
2018-11-07 $0.3700 0.37%
2018-08-15 $0.3700 0.37%
2018-05-09 $0.3500 0.39%
2018-02-07 $0.3500 0.41%
2017-11-08 $0.3500 0.46%
2017-08-15 $0.3500 0.53%
2017-05-09 $0.3300 0.54%
2017-02-07 $0.3300 0.53%
2016-11-08 $0.3300 0.64%
2016-08-16 $0.3300 0.53%
How RMD Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap31.08B
Enterprise Value30.27B
Trailing P/E20.68
Forward P/E17.74
PEG Ratio (5yr)1.21
Price/Sales (ttm)5.61
Price/Book (mrq)4.79
EV/Revenue5.47
EV/EBITDA14.28
Share Statistics
Avg Vol (3m)1.55M
Shares Outstanding145.06M
Float144.16M
% Held by Insiders0.50%
% Held by Institutions69.91%
Short Ratio7.77
Short % of Float10.76%
Profitability
Gross Margin62.18%
Operating Margin (ttm)35.33%
Profit Margin27.44%
Return on Assets (ttm)14.71%
Return on Equity (ttm)25.25%
Income Statement
Revenue (ttm)5.54B
Revenue Growth (yoy)10.80%
Gross Profit (ttm)3.44B
EBITDA2.12B
Net Income (ttm)1.52B
Diluted EPS (ttm)10.36
EPS Growth (yoy)10.50%
Balance Sheet
Total Cash (mrq)1.66B
Total Debt (mrq)843.17M
Debt / Equity (mrq)12.99
Current Ratio (mrq)3.01
Book Value / Share44.76
Operating CF (ttm)1.89B
Free Cash Flow (ttm)1.45B
Trading & Dividends
Beta (5Y)0.78
50-Day MA199.07
200-Day MA232.64
Fwd Dividend Yield115.00%
Payout Ratio22.47%
Ownership Breakdown
Institutional 69.91% Insider 0.50% Public 29.6%
Short Interest 10.76% of float
High
Institutional 13F Holdings

Famous investors who disclosed a position in RMD in their latest SEC 13F filing.

Loading…
Insider Transactions
DateInsiderRoleTransactionSharesValue
2026-06-08 FARRELL MICHAEL J Chief Executive Officer Sale at price 193.96 per share. 4,991 $968,064
2026-06-08 FARRELL MICHAEL J Chief Executive Officer Conversion of Exercise of derivative security at price 146.34 per share. 4,991 $730,383
2026-05-07 FARRELL MICHAEL J Chief Executive Officer Sale at price 207.82 per share. 4,991 $1,037,233
2026-05-07 FARRELL MICHAEL J Chief Executive Officer Conversion of Exercise of derivative security at price 146.34 per share. 4,991 $730,383
2026-04-07 FARRELL MICHAEL J Chief Executive Officer Sale at price 225.50 per share. 4,991 $1,125,486
2026-04-07 FARRELL MICHAEL J Chief Executive Officer Conversion of Exercise of derivative security at price 146.34 per share. 4,991 $730,383
2026-04-01 SANDERCOCK BRETT Chief Financial Officer Sale at price 224.31 per share. 1,000 $224,310
2026-04-01 FARRELL PETER CRAIG Director Sale at price 225.00 per share. 2,000 $450,000
2026-03-09 FARRELL MICHAEL J Chief Executive Officer Sale at price 251.03 per share. 4,991 $1,252,902
2026-03-09 FARRELL MICHAEL J Chief Executive Officer Conversion of Exercise of derivative security at price 146.34 per share. 4,991 $730,383
2026-03-04 FARRELL PETER CRAIG Director Sale at price 260.22 per share. 2,000 $520,440
2026-03-02 SANDERCOCK BRETT Chief Financial Officer Sale at price 254.30 per share. 1,000 $254,300
2026-02-09 FARRELL MICHAEL J Chief Executive Officer Sale at price 273.78 per share. 4,991 $1,366,436
2026-02-09 FARRELL MICHAEL J Chief Executive Officer Conversion of Exercise of derivative security at price 146.34 per share. 4,991 $730,383
2026-02-04 FARRELL PETER CRAIG Director Sale at price 251.31 per share. 2,000 $502,620
2026-02-04 RIDER MICHAEL J General Counsel Sale at price 260.00 per share. 50 $13,000
2026-02-02 SANDERCOCK BRETT Chief Financial Officer Sale at price 257.03 per share. 1,000 $257,030
2026-01-07 FARRELL PETER CRAIG Director Sale at price 248.83 per share. 2,000 $497,660
2026-01-07 FARRELL MICHAEL J Chief Executive Officer Sale at price 248.46 per share. 4,991 $1,240,065
2026-01-07 FARRELL MICHAEL J Chief Executive Officer Conversion of Exercise of derivative security at price 146.34 per share. 4,991 $730,383
2026-01-02 SANDERCOCK BRETT Chief Financial Officer Sale at price 241.75 per share. 1,000 $241,750
2026-01-02 RIDER MICHAEL J Officer Sale at price 241.75 per share. 50 $12,088
2025-12-08 FARRELL MICHAEL J Chief Executive Officer Sale at price 251.41 per share. 4,991 $1,254,796
2025-12-08 FARRELL MICHAEL J Chief Executive Officer Conversion of Exercise of derivative security at price 146.34 per share. 4,991 $730,383
2025-12-03 FARRELL PETER CRAIG Director Sale at price 251.47 per share. 2,000 $502,940
FARRELL MICHAEL J Chief Executive Officer
Sale at price 193.96 per share.
2026-06-08 4,991 sh $968,064
FARRELL MICHAEL J Chief Executive Officer
Conversion of Exercise of derivative security at price 146.34 per share.
2026-06-08 4,991 sh $730,383
FARRELL MICHAEL J Chief Executive Officer
Sale at price 207.82 per share.
2026-05-07 4,991 sh $1,037,233
FARRELL MICHAEL J Chief Executive Officer
Conversion of Exercise of derivative security at price 146.34 per share.
2026-05-07 4,991 sh $730,383
FARRELL MICHAEL J Chief Executive Officer
Sale at price 225.50 per share.
2026-04-07 4,991 sh $1,125,486
FARRELL MICHAEL J Chief Executive Officer
Conversion of Exercise of derivative security at price 146.34 per share.
2026-04-07 4,991 sh $730,383
SANDERCOCK BRETT Chief Financial Officer
Sale at price 224.31 per share.
2026-04-01 1,000 sh $224,310
FARRELL PETER CRAIG Director
Sale at price 225.00 per share.
2026-04-01 2,000 sh $450,000
FARRELL MICHAEL J Chief Executive Officer
Sale at price 251.03 per share.
2026-03-09 4,991 sh $1,252,902
FARRELL MICHAEL J Chief Executive Officer
Conversion of Exercise of derivative security at price 146.34 per share.
2026-03-09 4,991 sh $730,383
FARRELL PETER CRAIG Director
Sale at price 260.22 per share.
2026-03-04 2,000 sh $520,440
SANDERCOCK BRETT Chief Financial Officer
Sale at price 254.30 per share.
2026-03-02 1,000 sh $254,300
FARRELL MICHAEL J Chief Executive Officer
Sale at price 273.78 per share.
2026-02-09 4,991 sh $1,366,436
FARRELL MICHAEL J Chief Executive Officer
Conversion of Exercise of derivative security at price 146.34 per share.
2026-02-09 4,991 sh $730,383
FARRELL PETER CRAIG Director
Sale at price 251.31 per share.
2026-02-04 2,000 sh $502,620
RIDER MICHAEL J General Counsel
Sale at price 260.00 per share.
2026-02-04 50 sh $13,000
SANDERCOCK BRETT Chief Financial Officer
Sale at price 257.03 per share.
2026-02-02 1,000 sh $257,030
FARRELL PETER CRAIG Director
Sale at price 248.83 per share.
2026-01-07 2,000 sh $497,660
FARRELL MICHAEL J Chief Executive Officer
Sale at price 248.46 per share.
2026-01-07 4,991 sh $1,240,065
FARRELL MICHAEL J Chief Executive Officer
Conversion of Exercise of derivative security at price 146.34 per share.
2026-01-07 4,991 sh $730,383
SANDERCOCK BRETT Chief Financial Officer
Sale at price 241.75 per share.
2026-01-02 1,000 sh $241,750
RIDER MICHAEL J Officer
Sale at price 241.75 per share.
2026-01-02 50 sh $12,088
FARRELL MICHAEL J Chief Executive Officer
Sale at price 251.41 per share.
2025-12-08 4,991 sh $1,254,796
FARRELL MICHAEL J Chief Executive Officer
Conversion of Exercise of derivative security at price 146.34 per share.
2025-12-08 4,991 sh $730,383
FARRELL PETER CRAIG Director
Sale at price 251.47 per share.
2025-12-03 2,000 sh $502,940